AIS: Clinical Trials

18 trials for AIS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 not yet recruiting, 3 recruiting, 3 unknown. 6 Not applicable, 6 Phase 3, 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable6Not yet recruiting 3, Completed 1, Recruiting 1, Unknown 1
Phase 36Completed 2, Recruiting 2, Terminated 1, Unknown 1
Phase 12Completed 1, Not yet recruiting 1
Phase 21Completed 1

Follow AIS: new trials by email Literature Review of AIS trials Research Report on AIS

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smartphone App for Adolescents With Idiopathic Scoliosis
DinSkoliose smartphone application - Adolescence Idiopathic Scoliosis, AIS
Not applicableNot yet recruitingOslo Metropolitan University302028-04-012026-07-07
Endovascular Treatment for Acute Large Vessel Occlusion With Ultra-Large Ischemic Core
Patients assigned to the EVT group should undergo EVT as soon as possible, followed by BMM according to the current EVT guidelines., The medical group receives BMM alone. EVT is not performed in the medical group. - AIS, Stroke
Not applicableNot yet recruitingFirst Affiliated Hospital of Harbin Medical University4502026-09-182026-08-28
A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke
Placebo of Human Umbilical Cord Mesenchymal Stromal Cells Injection, Human Umbilical Cord Mesenchymal Stem Cells Injection - Acute Ischemic Stroke, AIS
Phase 1Not yet recruitingBOE Technology Group Co., Ltd.352026-06-302026-06-05
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
BXOS110, placebo - AIS
Phase 3RecruitingBiocells (Beijing) Biotech Co.,Ltd11122026-01-192026-04-09
A Randomized Clinical Trial on Urgent Angioplasty for IntraCranial Atherosclerotic Stenosis-related Large-Vessel Occlusion After Mechanical Thrombectomy
balloon dilatation and/or stenting, medication - AIS, ICAS - Intracranial Atherosclerosis
Not applicableNot yet recruitingChanghai Hospital6122025-03-152025-03-18
Cervical Alignment Changes After Correction of Thoracic Adolescent Idiopathic Scoliosis With Thoracic Hypokyphosis
AIS, Cervical Alignment
CompletedIstituto Ortopedico Rizzoli572023-04-302025-03-19
Search for a Recanalization of the Sylvian Artery Electro-Physiological Biomarker
Placement of the EGG - AIS
CompletedFondation Ophtalmologique Adolphe de Rothschild152023-01-242025-06-25
A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha), Placebo - Cervical Cancer, Genital Wart
Phase 3TerminatedShanghai Bovax Biotechnology Co., Ltd.31312022-12-092023-07-21
Screening and Intervention for AIS in Haikou, Hainan Province, China
Exercise, Brace - AIS
Not applicableRecruitingChaoyin Jiang50002022-10-242023-08-04
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
9-valent HPV vaccine - HPV Infections, Cervical Cancer
Phase 3UnknownShanghai Bovax Biotechnology Co., Ltd.12002021-05-282024-04-17
Investigating the Potential Psychological Impact of Early Screening and Long-term Monitoring for Adolescent Idiopathic Scoliosis Among Patients and Caregivers
Adolescent Idiopathic Scoliosis, AIS
UnknownThe University of Hong Kong1502021-02-012021-12-09
A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke
Tianyi Revascularization Device, Solitaire FR Revascularization Device - AIS, Acute Ischemic Stroke
Not applicableCompletedSuzhou Zenith Vascular SciTech Limited2382021-01-242022-08-11
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58), Active Comparator: GARDASIL ®9 - HPV Infections, Cervical Cancer
Phase 3CompletedShanghai Bovax Biotechnology Co., Ltd.12002020-09-192023-11-24
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL® - Cervical Cancer, Vulvar Cancer
Phase 3CompletedShanghai Bovax Biotechnology Co., Ltd.16802020-05-282022-02-25
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha), GARDASIL® - Cervical Cancer, Vulvar Cancer
Phase 3RecruitingShanghai Bovax Biotechnology Co., Ltd.80002020-04-282024-06-07
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
9-valent HPV Recombinant Vaccine, Placebo - Cervical Cancers, Vulvar Cancer
Phase 1CompletedShanghai Bovax Biotechnology Co., Ltd.902018-10-102020-01-22
NBP in Adult Patients With Acute Ischemic Stroke (AIS)
NBP Softgel Capsules, Placebo - AIS
Phase 2CompletedCSPC-NBP Pharmaceutical Co., Ltd.1772018-02-282020-09-17
Evaluation of the AIIS Using Hip Ultrasound(AIISUS)
ultrasound scan of the hip - AIS
Not applicableUnknownTel-Aviv Sourasky Medical Center502017-04-012017-04-07

Narrower conditions

Condylomata Acuminata (6)  ·  Uterine Cervical Neoplasms (6)  ·  Vaginal Neoplasms (5)  ·  Vulvar Neoplasms (5)  ·  Ischemic Stroke (2)  ·  Papillomavirus Infections (2)  ·  Scoliosis (2)  ·  Stroke (2)  ·  Alzheimer Disease (1)  ·  Intracranial Arteriosclerosis (1)  ·  Treatment Adherence and Compliance (1)

Broader conditions

Communicable Diseases (6)  ·  DNA Virus Infections (6)  ·  Disease Attributes (6)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Genital Diseases (6)  ·  Genital Diseases, Female (6)  ·  Genital Neoplasms, Female (6)  ·  Infections (6)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Sexually Transmitted Diseases (6)  ·  Sexually Transmitted Diseases, Viral (6)

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (2)  ·  Vaccines, Synthetic (2)  ·  Braces (1)  ·  Dosage Forms (1)  ·  Exercise (1)

Sponsors

Shanghai Bovax Biotechnology Co., Ltd. (6)  ·  BOE Technology Group Co., Ltd. (1)  ·  Biocells (Beijing) Biotech Co.,Ltd (1)  ·  CSPC-NBP Pharmaceutical Co., Ltd. (1)  ·  Changhai Hospital (1)  ·  Chaoyin Jiang (1)  ·  First Affiliated Hospital of Harbin Medical University (1)  ·  Fondation Ophtalmologique Adolphe de Rothschild (1)  ·  Istituto Ortopedico Rizzoli (1)  ·  Oslo Metropolitan University (1)  ·  Suzhou Zenith Vascular SciTech Limited (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  The University of Hong Kong (1)

Countries

China (11)  ·  France (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Norway (1)  ·  United States (1)

Top investigators

Jianmin Liu, MD, PhD (2)  ·  Huaizhang Shi, MD, PhD (1)  ·  Wayne Clarke, MD (1)  ·  Wei Hu, MD, PhD (1)